Skip to main content
. 2022 Dec 5;2022:7993579. doi: 10.1155/2022/7993579

Table 1.

The list of included studies on skin disease therapeutic effects with N. sativa.

Authors/years Study design Type of skin disease Age Sample size Forms of drug use Dosage Duration Improvement frequency Clinical score index before/after treatment References
Stern et al./2002 Prospective Atopic dermatitis Nr 20 Topical (ointment) 15% black seed oil other daily 4 weeks Nr 1.71/1.01% [10]
Kalus et al./2003 Double-blinded RCT Atopic eczema 6–19 63 Oral (500 mg capsule) Seed oil (40 mg/kg) three times a day 8 weeks Invention group = 25/41, control = 9/22 Nr [11]
Rezaei et al./2005 Double-blinded RCT Wart 12–18 291 Topical (ointment) 30 g crude extract twice daily 6 weeks Invention group = 42/43, control = 10/20 Nr [12]
Nawab et al./2008 Before and after Eczema 10–70 30 Topical (lotion) 25 mg oil 4 times a day 6 weeks Nr Eczema severity (itching) = 30/9 (papules) 19/4 [13]
Al-Harchon/2010 Single-blind RCT Acne vulgaris 13–23 93 Topical (lotion) 10% oil twice daily 8 weeks Invention group = 25/47, control = 3/38 Nr [14]
Nilforoushzadeh et al./2010 Double-blinded RCT Acute cutaneous leshmaniasis 20/81 ± 12/26 150 Topical (lotion) 60% oil twice daily 12 weeks Invention group = 61/75, control = 48/75 Nr [15]
Yousefi et al./2013 Double-blinded RCT Eczema 18–60 60 Topical (lotion) 1 g seed oil twice daily 4 weeks Nr Nr [16]
Bashar et al./2014 Double-blind, RCT Arsenical keratosis 20–36 36 Oral (500 mg) Seed oil 8 weeks Nr Palmar arsenical keratosis: 99.3 ± 21.5 and 62.3 ± 14.3 [17]
Ahmed Jawad et al./2014 RCT Psoriasis 50–70 60 Topical (ointment), oral Crude extract (10% (w/w) and 500 mg capsule) three times daily 12 weeks Nr PASI (psoriasis area and severity index) score in group 1: 9.0 ± 3.7/4.3 ± 2.0, group 2: 9.9 ± 3.4/5.4 ± 2.7, Group 3: 10.9 ± 2.7/4.2 ± 1.7 [18]
Ghorbanibirgani et al./2014 Double blind, RCT Vitiligo 43.65 ± 3.21 52 Topical (lotion) 100 g seed oil 24 weeks Nr Vitiligo area scoring index in control group: 4.98 ± 4.81/4.62 ± 4.36, in invention 4.98 ± 4.81/3.75 ± 3.91 [19]
Rafati et al./2014 RCT Infant skin infections 6–11 days 60 Topical (lotion) 33% oil three times a day 4 days Nr Nr [20]
Rafati et al./2019 Double-blinded, RCT Acute radiation dermatitis ≥18 years 62 Topical (gel lotion) 50 g gel lotion 5% twice a day 6 weeks Nr Nr [21]
Sarac et al./2019 Clinical trials with a pre- and a post-treatment Vitiligo 20–85 33 Topical (cream) Oil/twice a day 24 weeks Invention group = 23/33 Nr [22]
Soleymani et al./2020 Double-blind RCT Acne 14–35 60 Topical (gel lotion) 1% oil/twice a day 8 weeks Nr Comedone number invention = 8.07 ± 6.142/1.11 ± 1.812, in control + 8.87 ± 5.526/8.44 ± 5.437, papule number invention: 11.47 ± 6.426/1.89 ± 1.729, in control = 8.43 ± 4.116/7.31 ± 4.306 [23]

Nr: not reported.